{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:19:46Z","timestamp":1787019586531,"version":"build-2736575974"},"reference-count":52,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,4,13]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Joint and bone healing abnormalities are demonstrated in hemophilic mice that are not solely because of the amount of blood in their joints. Following initial hemostasis, extended FIX activity is needed in the week after hemarthrosis to normalize osteochondral healing.<\/jats:p>","DOI":"10.1182\/blood-2016-08-734053","type":"journal-article","created":{"date-parts":[[2016,12,30]],"date-time":"2016-12-30T21:30:26Z","timestamp":1483133426000},"page":"2161-2171","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":44,"title":["Abnormal joint and bone wound healing in hemophilia mice is improved by extending factor IX activity after hemarthrosis"],"prefix":"10.1182","volume":"129","author":[{"given":"Junjiang","family":"Sun","sequence":"first","affiliation":[{"name":"Gene Therapy Center, University of North Carolina, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baolai","family":"Hua","sequence":"additional","affiliation":[{"name":"Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric W.","family":"Livingston","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, University of North Carolina, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2110-0740","authenticated-orcid":false,"given":"Sarah","family":"Taves","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, University of North Carolina, Chapel Hill, NC;"},{"name":"Global Research, Novo Nordisk A\/S, Mal\u00f8v, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Johansen","sequence":"additional","affiliation":[{"name":"Global Research, Novo Nordisk A\/S, Mal\u00f8v, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureane","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Department of Pathology, Duke University and Durham Veterans Affairs Medical Centers, Durham, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirella","family":"Ezban","sequence":"additional","affiliation":[{"name":"Global Research, Novo Nordisk A\/S, Mal\u00f8v, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dougald M.","family":"Monroe","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted A.","family":"Bateman","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, University of North Carolina, Chapel Hill, NC;"},{"name":"Department of Radiation Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6759-9888","authenticated-orcid":false,"given":"Paul E.","family":"Monahan","sequence":"additional","affiliation":[{"name":"Gene Therapy Center, University of North Carolina, Chapel Hill, NC;"},{"name":"Harold R. Roberts Comprehensive Hemophilia Diagnosis and Treatment Center, University of North Carolina, Chapel Hill, NC; and"},{"name":"Shire Plc, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"5","key":"2019111903521732100_B1","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2141.2008.07386.x","article-title":"Understanding haemophilic arthropathy: an exploration of current open issues","volume":"143","author":"Jansen","year":"2008","journal-title":"Br J Haematol"},{"issue":"6","key":"2019111903521732100_B2","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1002\/art.20284","article-title":"Initiation of degenerative joint damage by experimental bleeding combined with loading of the joint: a possible mechanism of hemophilic arthropathy","volume":"50","author":"Hooiveld","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2019111903521732100_B3","doi-asserted-by":"crossref","first-page":"R148","DOI":"10.1186\/ar4331","article-title":"Repeated autologous intraarticular blood injections as an animal model for joint pain in haemophilic arthropathy","volume":"15","author":"Boettger","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"2019111903521732100_B4","first-page":"339","article-title":"Blood-induced joint damage: longterm effects in vitro and in vivo","volume":"30","author":"Hooiveld","year":"2003","journal-title":"J Rheumatol"},{"issue":"suppl 1","key":"2019111903521732100_B5","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/j.thromres.2010.01.043","article-title":"Wound healing in hemophilia B mice and low tissue factor mice","volume":"125","author":"Monroe","year":"2010","journal-title":"Thromb Res"},{"issue":"9","key":"2019111903521732100_B6","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1182\/blood-2006-05-020495","article-title":"Cutaneous wound healing is impaired in hemophilia B","volume":"108","author":"Hoffman","year":"2006","journal-title":"Blood"},{"issue":"4","key":"2019111903521732100_B7","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1365-2516.2008.01689.x","article-title":"Experimental haemophilic arthropathy in a mouse model of a massive haemarthrosis: gross, radiological and histological changes","volume":"14","author":"Hakobyan","year":"2008","journal-title":"Haemophilia"},{"issue":"12","key":"2019111903521732100_B8","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2008-01-131417","article-title":"Intraarticular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX","volume":"112","author":"Sun","year":"2008","journal-title":"Blood"},{"issue":"5","key":"2019111903521732100_B9","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/jth.12176","article-title":"IL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophilia","volume":"11","author":"Narkbunnam","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2019111903521732100_B10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/jth.12101","article-title":"Nuclear factor (NF)-\u03baB and its associated pathways are major molecular regulators of blood-induced joint damage in a murine model of hemophilia","volume":"11","author":"Sen","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2019111903521732100_B11","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1538-7836.2008.02954.x","article-title":"Hemostatic effect of recombinant factor VIIa, NN1731 and recombinant factor VIII on needle-induced joint bleeding in hemophilia A mice","volume":"6","author":"\u00d8vlisen","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2019111903521732100_B12","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1365-2516.2008.01973.x","article-title":"IL-1 beta, IL-6, KC and MCP-1 are elevated in synovial fluid from haemophilic mice with experimentally induced haemarthrosis","volume":"15","author":"\u00d8vlisen","year":"2009","journal-title":"Haemophilia"},{"issue":"1","key":"2019111903521732100_B13","first-page":"173","article-title":"Haemarthrosis stimulates the synovial fibrinolytic system in haemophilic mice","volume":"110","author":"Nieuwenhuizen","year":"2013","journal-title":"Thromb Haemost"},{"issue":"4","key":"2019111903521732100_B14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/bjh.12148","article-title":"A single intra-articular injection with IL-4 plus IL-10 ameliorates blood-induced cartilage degeneration in haemophilic mice","volume":"160","author":"van Meegeren","year":"2013","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111903521732100_B15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/hum.2014.106","article-title":"Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trial","volume":"26","author":"Monahan","year":"2015","journal-title":"Hum Gene Ther"},{"issue":"6","key":"2019111903521732100_B16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa067659","article-title":"Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia","volume":"357","author":"Manco-Johnson","year":"2007","journal-title":"N Engl J Med"},{"issue":"suppl 4","key":"2019111903521732100_B17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/hae.12429","article-title":"Haemophilia care - beyond the treatment guidelines","volume":"20","author":"Srivastava","year":"2014","journal-title":"Haemophilia"},{"issue":"4","key":"2019111903521732100_B18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/hae.12902","article-title":"Recombinant long-acting glycoPEGylated factor IX (nonacog beta pegol) in haemophilia B: assessment of target joints in multinational phase 3 clinical trials","volume":"22","author":"Negrier","year":"2016","journal-title":"Haemophilia"},{"key":"2019111903521732100_B19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.thromres.2016.02.030","article-title":"Nonacog beta pegol (N9-GP) in haemophilia B: A multinational phase III safety and efficacy extension trial (paradigm\u21224)","volume":"141","author":"Young","year":"2016","journal-title":"Thromb Res"},{"issue":"10","key":"2019111903521732100_B20","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1182\/blood-2011-02-335596","article-title":"Enhanced pharmacokinetic properties of a glycoPEGylated recombinant factor IX: a first human dose trial in patients with hemophilia B","volume":"118","author":"Negrier","year":"2011","journal-title":"Blood"},{"issue":"26","key":"2019111903521732100_B21","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1182\/blood-2014-05-573055","article-title":"Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial","volume":"124","author":"Collins","year":"2014","journal-title":"Blood"},{"issue":"8","key":"2019111903521732100_B22","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1182\/blood-2011-02-336172","article-title":"Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide","volume":"118","author":"\u00d8stergaard","year":"2011","journal-title":"Blood"},{"issue":"10","key":"2019111903521732100_B23","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1182\/blood.V90.10.3962","article-title":"A coagulation factor IX-deficient mouse model for human hemophilia B","volume":"90","author":"Lin","year":"1997","journal-title":"Blood"},{"issue":"6","key":"2019111903521732100_B24","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1182\/blood-2004-01-0138","article-title":"Creation of a mouse expressing defective human factor IX","volume":"104","author":"Jin","year":"2004","journal-title":"Blood"},{"issue":"6","key":"2019111903521732100_B25","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1365-2516.2006.01348.x","article-title":"Histological changes in murine haemophilic synovitis: a quantitative grading system to assess blood-induced synovitis","volume":"12","author":"Valentino","year":"2006","journal-title":"Haemophilia"},{"issue":"5","key":"2019111903521732100_B26","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/hae.12399","article-title":"Joint bleeding in factor VIII deficient mice causes an acute loss of trabecular bone and calcification of joint soft tissues which is prevented with aggressive factor replacement","volume":"20","author":"Lau","year":"2014","journal-title":"Haemophilia"},{"issue":"8","key":"2019111903521732100_B27","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1538-7836.2007.02647.x","article-title":"Restoring hemostatic thrombin generation at the time of cutaneous wounding does not normalize healing in hemophilia B","volume":"5","author":"McDonald","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2019111903521732100_B28","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/hae.12220","article-title":"Progressive improvement in wound healing with increased therapy in haemophilia B mice","volume":"19","author":"Monroe","year":"2013","journal-title":"Haemophilia"},{"issue":"11","key":"2019111903521732100_B29","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/ajh.24133","article-title":"Vascular remodeling underlies rebleeding in hemophilic arthropathy","volume":"90","author":"Bhat","year":"2015","journal-title":"Am J Hematol"},{"issue":"1","key":"2019111903521732100_B30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-2141.2012.09101.x","article-title":"Decreased bone density and bone strength in a mouse model of severe factor VIII deficiency","volume":"158","author":"Liel","year":"2012","journal-title":"Br J Haematol"},{"issue":"6","key":"2019111903521732100_B31","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/hae.12195","article-title":"The bone disease associated with factor VIII deficiency in mice is secondary to increased bone resorption","volume":"19","author":"Recht","year":"2013","journal-title":"Haemophilia"},{"issue":"1","key":"2019111903521732100_B32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/hae.12240","article-title":"Bone density in haemophilia: a single institutional cross-sectional study","volume":"20","author":"Kempton","year":"2014","journal-title":"Haemophilia"},{"issue":"2","key":"2019111903521732100_B33","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2516.2008.01963.x","article-title":"Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia","volume":"15","author":"Gerstner","year":"2009","journal-title":"Haemophilia"},{"issue":"1","key":"2019111903521732100_B34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2516.2008.01912.x","article-title":"Long-term prophylaxis in severe haemophilia seems to preserve bone mineral density","volume":"15","author":"Khawaji","year":"2009","journal-title":"Haemophilia"},{"issue":"2","key":"2019111903521732100_B35","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2516.2011.02616.x","article-title":"Boys with haemophilia have low trabecular bone mineral density and sarcopenia, but normal bone strength at the radius","volume":"18","author":"Soucek","year":"2012","journal-title":"Haemophilia"},{"issue":"2","key":"2019111903521732100_B36","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1542\/peds.114.2.e177","article-title":"Reduced bone density among children with severe hemophilia","volume":"114","author":"Barnes","year":"2004","journal-title":"Pediatrics"},{"issue":"1","key":"2019111903521732100_B37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/hae.12565","article-title":"A case-control study assessing bone mineral density in severe haemophilia A in the UK","volume":"21","author":"Wells","year":"2015","journal-title":"Haemophilia"},{"issue":"2","key":"2019111903521732100_B38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1756-185X.2009.01394.x","article-title":"Reduced bone density in individuals with severe hemophilia B","volume":"12","author":"Mansouritorghabeh","year":"2009","journal-title":"Int J Rheum Dis"},{"issue":"13","key":"2019111903521732100_B39","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1182\/blood-2014-10-602060","article-title":"Premature changes in trabecular and cortical microarchitecture result in decreased bone strength in hemophilia","volume":"125","author":"Lee","year":"2015","journal-title":"Blood"},{"issue":"2","key":"2019111903521732100_B40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1084\/jem.90.2.97","article-title":"Canine hemophilia; observations on the course, the clotting anomaly, and the effect of blood transfusions","volume":"90","author":"Graham","year":"1949","journal-title":"J Exp Med"},{"key":"2019111903521732100_B41","first-page":"1269","article-title":"Hemophilic arthropathy in dogs","volume":"8","author":"Swanton","year":"1959","journal-title":"Lab Invest"},{"issue":"6","key":"2019111903521732100_B42","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/jth.13328","article-title":"The F8(-\/-) rat as a model of hemophilic arthropathy","volume":"14","author":"S\u00f8rensen","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2019111903521732100_B43","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1172\/JCI115737","article-title":"Enhancement of incisional wound healing and neovascularization in normal rats by thrombin and synthetic thrombin receptor-activating peptides","volume":"89","author":"Carney","year":"1992","journal-title":"J Clin Invest"},{"issue":"3","key":"2019111903521732100_B44","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1067-1927.2005.00130311.x","article-title":"Activated protein C prevents inflammation yet stimulates angiogenesis to promote cutaneous wound healing","volume":"13","author":"Jackson","year":"2005","journal-title":"Wound Repair Regen"},{"issue":"5","key":"2019111903521732100_B45","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.ajpath.2011.07.024","article-title":"Protease activated receptor-2 mediates activated protein C-induced cutaneous wound healing via inhibition of p38","volume":"179","author":"Julovi","year":"2011","journal-title":"Am J Pathol"},{"issue":"4","key":"2019111903521732100_B46","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S8756-3282(03)00209-6","article-title":"Inhibition of osteoblast apoptosis by thrombin","volume":"33","author":"Pagel","year":"2003","journal-title":"Bone"},{"issue":"5","key":"2019111903521732100_B47","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.bone.2008.12.031","article-title":"Thrombin-stimulated growth factor and cytokine expression in osteoblasts is mediated by protease-activated receptor-1 and prostanoids","volume":"44","author":"Pagel","year":"2009","journal-title":"Bone"},{"issue":"2","key":"2019111903521732100_B48","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.thromres.2009.09.005","article-title":"Activated protein C stimulates osteoblast proliferation via endothelial protein C receptor","volume":"125","author":"Kurata","year":"2010","journal-title":"Thromb Res"},{"issue":"12","key":"2019111903521732100_B49","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/jor.22726","article-title":"Activated protein C (APC) can increase bone anabolism via a protease-activated receptor (PAR)1\/2 dependent mechanism","volume":"32","author":"Shen","year":"2014","journal-title":"J Orthop Res"},{"issue":"11","key":"2019111903521732100_B50","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1161\/01.ATV.0000244680.14653.9a","article-title":"Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis","volume":"26","author":"Mosnier","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"2019111903521732100_B51","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1055\/s-0037-1616530","article-title":"The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration","volume":"86","author":"Mosnier","year":"2001","journal-title":"Thromb Haemost"},{"issue":"4","key":"2019111903521732100_B52","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2516.2011.02728.x","article-title":"Perioperative clotting factor replacement and infection in total knee arthroplasty","volume":"18","author":"Wong","year":"2012","journal-title":"Haemophilia"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/15\/2161\/1399899\/blood734053.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/15\/2161\/1399899\/blood734053.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T03:52:40Z","timestamp":1574135560000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/15\/2161\/36398\/Abnormal-joint-and-bone-wound-healing-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,13]]},"references-count":52,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2017,4,13]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-08-734053","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,13]]}}}